HEATHER ROGERS: Open Payments
NPI 1528637204 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,504 in 95 payments from 13 companies in 2025. Trend: 2023 $354 · 2024 $1,475 · 2025 $1,504
Food & beverage: $1,504
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $530 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 34 | $286 |
| Otsuka America Pharmaceutical, Inc. | 9 | $246 |
| Janssen Pharmaceuticals, Inc | 10 | $168 |
| Collegium Pharmaceutical, Inc. | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, ABILIFY MAINTENA, Jornay PM, COBENFY, Qelbree.
Industry payments across OK — which companies pay providers there.
